GGrantIndex
Sort

1,049,261 grants matching t cell

Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer

$2,287,595
Robert J Coffey · Vanderbilt University Medical Center · P50 · FY2022 · CA

Isolation and Deep Sequencing of Monoclonal Antibodies Against HIV

$2,287,556
John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Gene regulatory elements, networks, and mechanisms

$2,287,519
Raja Jothi · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

Engineered platelets for the targeted destruction of circulating tumor cells

$2,287,500
Tara Lynn Deans · University Of Utah · DP2 · FY2019 · CA

A Novel 3D Bioprinted Smart Vascularized Nano Tissue

$2,287,500
Lijie Grace Zhang · George Washington University · DP2 · FY2014 · EB

HIGH-SENSITIVITY NMR AT ROOM TEMPERATURE FOR MOLECULAR STRUCTURE AND DYNAMICS

$2,287,500
Alexander Benjamin Barnes · Washington University · DP2 · FY2015 · GM

Self-Organization of the Human Genome

$2,287,500
Steven Todd Kosak · Northwestern University At Chicago · DP2 · FY2011 · OD

Human Interferons: Structure and Function

$2,287,483
Kathryn C. Zoon · Niaid Extramural Activities · Z01 · FY2007 · AI

Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management

$2,287,391
Michael S Gold · University Of Pittsburgh At Pittsburgh · UH3 · FY2021 · TR

T-Cell Receptor Gene Therapy for Human Cancers-Cures

$2,287,338
Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Post-transcriptional regulation of energy usage: glucose and lipid metabolism

$2,287,228
Myriam Gorospe · National Institute On Aging · ZIA · FY2020 · AG

Center for Modeling Integrated Metabolic Systems (MIMS)

$2,287,071
Case Western Reserve University · P50 · FY2004 · GM

A Massive Library of AAVs to Target Transcriptionally-Defined Primate Cell Types

$2,287,014
William Richard Stauffer · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · MH

Mechanobiology of the Cellular Glycocalyx

$2,286,959
Matthew J Paszek · Cornell University · DP2 · FY2015 · GM

NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER

$2,286,859
University Of California San Francisco · P60 · FY2001 · HL

Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers

$2,286,821
Paul M. Lieberman · Wistar Institute · P01 · FY2024 · CA

Mayo Clinic Hepatobiliary SPORE

$2,286,710
Mark A. Mc Niven · Mayo Clinic Rochester · P50 · FY2025 · CA

S.P.O.R.E. in Prostate Cancer

$2,286,693
University Of Michigan At Ann Arbor · P50 · FY2004 · CA

Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion

$2,286,537
James C. Zimring · University Of Virginia · P01 · FY2024 · HL

SPORE in Soft Tissue Sarcoma

$2,286,505
Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA

Pharmacokinetics and Drug Metabolism

$2,286,500
Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR

Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers

$2,286,356
Jiayu Zhou · Michigan State University · RF1 · FY2021 · AG

Breast Cancer

$2,286,209
Walter C. Willett · Brigham And Women'S Hospital · P01 · FY2012 · CA

Cancer and Leukemia Group B CCOP Research Base

$2,286,202
Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2012 · CA

Radiation and checkpoint blockade for cancer immune therapy

$2,286,184
Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA